Recent research indicated that the inhibition of B cell metabolism mediated by two synergistic cytokines, TGF-β and IL-10, contributes to the induction of immune tolerance and could be a new therapeutic strategy for autoimmune diseases such as SLE [46]. Here, IL10 is linked to systemic lupus erythematosus.